We are live on
!
Find out more
GF
Genworth Financial Portfolio holdings
AUM
$486M
1-Year Est. Return
19.32%
This Fund
S&P 500
This Quarter
Est. Return
-3.91%
1 Year Est. Return
+19.32%
3 Year Est. Return
+64.01%
5 Year Est. Return
+73.19%
10 Year Est. Return
–
AUM
$285M
AUM Growth
-$12M
(-4%)
Cap. Flow
-$365K
Cap. Flow
% of AUM
-0.13%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mirum Pharmaceuticals
MIRM
|
+$309K |
| 2 |
ACLX
Arcellx
ACLX
|
+$56.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0% |
Similar funds
PE
SCA
ACM
LCWP
UOIF
HL
GRR
NFW
Genworth Financial's Q3 2023 Portfolio in Review
As of Q3 2023, Genworth Financial held 4 positions worth $285M, down 4% from $297M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Genworth Financial's Q3 2023 filing shows 2 closed positions. The largest sale was Mirum Pharmaceuticals, an estimated $309K.
By sector, the portfolio is most concentrated in Healthcare at 0% of assets, down from 0.12% a quarter earlier.
- Genworth Financial fully exited Mirum Pharmaceuticals in Q3 2023, selling an estimated $309K.
- Genworth Financial's ten largest holdings make up 100% of its $285M portfolio in Q3 2023.
- Genworth Financial opened 0 new positions and closed 2 in Q3 2023.
- Genworth Financial's portfolio value fell 4% quarter-over-quarter to $285M.
Based on Genworth Financial's 13F filing for Q3 2023, filed 25 Oct 2023.